Survey of cardiovascular events within six months after discharge and related factors in patients with acute myocardial infarction
Main Article Content
Abstract
Patients who survive after an myocardial infarction incidence remain at a high risk of mortality due to the occurrence of both short- and long-term cardiovascular events. Therefore, determining the incidence of these events as well as the associated risk factors is of great importance in patients’ management and treatment. A cross-sectional descriptive study with convenient sampling was performed on patients diagnosed with acute myocardial infarction and treated at the Interventional Cardiology Department of Can Tho Central General Hospital from December 2024 to September 2025. A total of 196 patients were included, with a mean age of 66.08 ± 10.58 years old, and male patients accounted for 71.4%. After 6 months of follow-up, 40 patients (20.4%) experienced cardiovascular events. Factors such as diabetes mellitus (OR = 2.93), dyslipidemia (OR = 2.27), and smoking (OR = 2.31) were significant risks factors of cardiovascular events. Multivariate analysis revealed that diabetes (OR = 2.59), dyslipidemia (OR = 3.06), smoking (OR = 2.63), GRACE score (OR = 0.97), and TIMI score (OR = 0.62) were independent factors associated with the occurrence of cardiovascular events. These findings indicate that the incidence of cardiovascular events within 6 months of follow-up among patients with acute myocardial infarction was relatively high. Diabetes mellitus, dyslipidemia, smoking, GRACE, TIMI scores were identified as independent predictors influencing the occurrence of cardiovascular events within 6 months after hospital discharge.
Article Details
Keywords
Acute myocardial infarction, cardiovascular events, related factors
References
2. Poudel I, Tejpal C, Rashid H, Jahan N. Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review. Cureus. 2019; 11(7): e5280. doi:10.7759/cureus.5280.
3. Wang X, Montero-Cabezas JM, Mandurino-Mirizzi A, et al. Prevalence and Long-term Outcomes of Patients with Coronary Artery Ectasia Presenting with Acute Myocardial Infarction. Am J Cardiol. 2021; 156: 9-15. doi:10.1016/j.amjcard.2021.06.037.
4. Ueeda M, Doumei T, Takaya Y, et al. Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction. Heart Vessels. 2011; 26(2): 145-152. doi:10.1007/s00380-010-0038-8.
5. Lee JH, Park HS, Chae SC, et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol. 2009; 104(2): 182-189. doi:10.1016/j.amjcard.2009.03.010.
6. Tian D, Yu N, Mao T, et al. Prediction of long-term major adverse cardiac events after myocardial infarction: value of combination of inflammatory biomarkers and GRACE score. Front Cardiovasc Med. 2025; 12: 1591578. doi:10.3389/fcvm.2025.1591578.
7. Pereira JL, Sakae TM, Machado MC. TIMI risk score for acute myocardial infarction according to prognostic stratification. Arquivos brasileiros de cardiologia. 2009; 93(2): 105-112. doi:10.1590/s0066-782x2009000800007.
8. Yang P, Duan J, Li M, et al. Construction and Validation of a Predictive Model for Long-Term Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction. Clin Interv Aging. 2024; 19: 1965-1977. doi:10.2147/CIA.S486839.
9. Han Z, et al. The independent value and clinical significance of angio-based microvascular resistance in predicting adverse cardiovascular events in patients with acute ST-elevation myocardial infarction. Front Cardiovasc Med. 2025; 12: 1637251. doi:10.3389/fcvm.2025.1637251.
10. Paolisso P, Foa A, Bergamaschi L, et al. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021; 20(1): 192. doi:10.1186/s12933-021-01384-6.
11. Jyotsna F, Ahmed A, Kumar K, et al. Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes. Cureus. 2023; 15(8): e43882. doi:10.7759/cureus.43882.